|
|
The following publications have been written about the Australasian Biospecimen Network: |
 |
Catchpoole, D., deFazio, A., Devereux, L., Fleming, M., Hof, M., Schmidt, C., Thorne, H. & Zeps, N. (2007) 'The importance of biorepository networks: The Australasian Biospecimen Network - Oncology', Australian Journal of Medical Science 28: 1, 16-20 |
|
Thorne, H., Catchpoole, D., Devereux, L. & Zeps, N. (2005) “A more auspicious start for the Australasian Biospecimen Network”, Journal of Clinical Investigation, http://www.jci.org/cgi/eletters/113/3/320#230 |
| |
|
| The following research has been published in 2010 using data or tissue specimens supplied by ABN-Oncology-affliated tissue banks: |
|
Thomas Dunwell, Luke Hesson, Tibor A Rauch, Lihui Wang, Richard E Clark, Ashraf Dallol, Dean Gentle, Daniel Catchpoole, Eamonn R Maher, Gerd P Pfeifer, Farida Latif A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers Molecular Cancer 2010, 9:44 |
|
James G Taylor, Adam T Cheuk, Patricia S Tsang, Joon-Yong Chung, Young K Song, Krupa Desai, Yanlin Yu, Qing-Rong Chen, Kushal Shah, Victoria Youngblood, JunFang, Su Yong Kim, Choh Yeung, Lee J. Helman, Arnulfo Mendoza, Vu Ngo, Louis M Staudt, Jun S Wei, Chand Khanna, Daniel Catchpoole, Stephen J Qualman, Stephen M Hewitt, glenn Merlino, Stephen J Chanock and Javed Khan. Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest. 2009;119(11):3395–3407 |
|
Platell C, Zeps N, Joseph D, Spry N, Iacopetta B, Caruso V. Tumour banking as part of routine clinical practice. ANZ J Surg. 2010 Apr;80(4):203-4. |
|
Ang PW, Loh M, Liem N, Lim PL, Grieu F, Vaithilingam A, Platell C, Yong WP, Iacopetta B, Soong R. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer. 2010 May 21;10:227. |
|
Johal H, Faedo M, Faltas J, Lau A, Mousina R, Cozzi P, DeFazio A, Rawlinson W. DNA of mouse mammary tumor virus-like virus is present in human tumors influenced by hormones. J Med Virol 2010; 82: 1044-50 |
|
Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, deFazio A, Bowtell D, Brenton JD. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 2010; 221: 49-56 |
| |
|
Research published in 2009 using tissue specimens supplied by ABN-Oncology-affiliated tissue banks |
|
Taylor, JG, Cheuk AT, Tsang PS, Chung J, Song YK, Desai K, Yu Y, Chen Q, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, and Khan J. Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models J Clin Invest. 2009;119(11):3395–3407 |
|
Luke B Hesson, Thomas L Dunwell, Wendy N Cooper, Daniel Catchpoole, Anna T Brini, Raffaella Chiaramonte, Mike Griffiths, Andrew D Chalmers, Eamonn R Maher, Farida Latif The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias Molecular Cancer 2009, 8:42 (2009) |
|
Thomas L. Dunwell, Luke B. Hesson, Tatiana Pavlova, Veronika Zabarovska, Daniel Catchpoole, Raffaella Chiaramonte, Anna T. Brini, Mike Griffiths, Eamonn R. Maher, Eugene Zabarovsky, Farida Latif. Epigenetic analysis of childhood acute lymphoblastic leukemia. Epigenetics 4:3, 185-193 |
|
Thomas L. Dunwell, Rachel E Dickinson, Tatjana Stankovic, Ashraf Dallol, Victoria Weston, Belinda Austen, Daniel Catchpoole, Eamonn R Maher, Farida Latif. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia. Epigenetics 4:4, 265-269 |
|
Kadupitige S.R., Leung K.C., Sellmeier J., Sivieng J., Catchpoole D.R., Bain M.E. and Gaëta B.A. MINER: exploratory analysis of gene interaction networks by machine learning from expression data BMC Genomics 2009, 10(Suppl 3):S17 |
|
Drake J, Shearwood AM, White J, Friis R, Zeps N, Charles A, Dharmarajan A Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours. Eur J Gynaecol Oncol. 2009;30(2):133-41. |
|
Krajewska M, Smith LH, Rong J, Huang X, Hyer ML, Zeps N, Iacopetta B, Linke SP, Olson AH, Reed JC, Krajewski S. Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections. J Histochem Cytochem 2009 57: 649-663 |
|
Soong R, Shah N, Peh BK, Chong PY, Ng SS, Zeps N, Joseph D, Salto-Tellez M, Iacopetta B, Ito Y. The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome British Journal of Cancer (2009) 100, 676 – 679 |
|
SC Naumann, WP Roos, E Jost, C Belohlavek, V Lennerz, CW Schmidt, M Christmann and B Kaina Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: reponse related to MGMT, MMR, DSBs, and p53 British Journal of Cancer (2009) 100, 322 – 333 |
|
Paul Salama, Michael Phillips, Fabienne Grieu, Melinda Morris, Nik Zeps, David Joseph, Cameron Platell, and Barry Iacopetta Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer J Clin Oncol 27:186-192 |
|
Schofield L, Watson N, Grieu F, Li WQ, Zeps N, Harvey J, Stewart C, Abdo M, Goldblatt J, Iacopetta B. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test Int. J. Cancer: 124, 1097–1102 (2009) |
|
Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G, Zhao Y, Zeng T, Glover JN, Vanderhyden B, Zhao C, Parkinson CA, Jimenez-Linan M, Bowtell DD, Mes-Masson AM, Brenton JD, Aparicio SA, Boyd N, Hirst M, Gilks CB, Marra M, Huntsman DG. Mutation of FOXL2 in granulosa-cell tumours of the ovary N Engl J Med 2009;360:2719-29 |
|
Etemadmoghadam D, deFazio A, Beroukhim R, Mermel C, George J, Getz G, Tothill R, Okamoto A, Raeder MB, AOCS Study Group, Harnett PR, Lade S, Akslen LA, Tinker A, Locandro B, Alsop K, Chiew Y-E, Traficante N, Fereday S, Johnson D, Fox S, Sellers W, Urashima M, Salvesen HB, Meyerson M and Bowtell D. Integrated genome-wide DNA Copy Number and expression analysis identifies distinct mechanisms of primary chemo-resistance in ovarian carcinomas Clin Cancer Res 2009;15:1417-1427 |
| |
|
Research published in 2008 using tissue specimens supplied by ABN-Oncology-affiliated tissue banks |
|
Nguyen Huu N, Ryder W, Zeps N, Flasza M, Chiu M, Hanby A, Poulsom R, Clarke R, Baron M. Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator J Pathol 2008; 216: 93–102 |
|
Creaney J, Segal A, Sterrett G, Platten MA, Baker E, Murch AR, Nowak AK, Robinson BW, Millward MJ. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma. Br J Cancer 98: 1562-1569 |
|
Creaney J, Yeoman D, Demelker Y, Segal A, Musk AW, Skates SJ, Robinson BW. Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma. Journal of Thoracic Oncology. 3(8):858-864 |
|
Catchpoole D.R., Guo D., Jiang H., Biesheuvel C. Predicting outcome in childhood acute lymphoblastic leukaemia using gene expression profiling: Prognostication or protocol selection? Blood 2008; 111(4): 2486-2487 |
|
Margetts C.D.E., Morris M., Astuti D., Gentle D.C., Cascon A., McRonald F.E., Catchpoole D.R., Robledo M., Neumann H.P.H., Latif F. and Maher E.R. Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma Endocrine-Related Cancer (2008) 15 777–786 |
|
Natrajan R, Warren W, Messahel B, Reis-Filho JS, Brundler MA, Dome JS, Grundy PE, Vujanic G, Pritchard Jones K, Jones C. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours J Clin Pathol 2008;61:95-102 |
|
Shehata M, Bièche I, Boutros R, Weidenhofer J, Fanayan S, Spalding L, Zeps N, Byth K, Bright RK, Lidereau R, Byrne JA. Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52 Clin Cancer Res 2008;14:5050-5060 |
|
Soong R, Shah N, Salto-Tellez M, Tai BC, Soo RA, Han HC, Ng SS, Tan WL, Zeps N, Joseph D, Diasio RB, Iacopetta B. Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy Annals of Oncology 19: 915–919, 2008 |
|
Tothill RW, Tinker AV, George J, Brown R, Fox SB, Johnson DS, Trivett, MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung J, Chiew, Y-E, Haviv I, AOCS Study Group, Gertig, D, deFazio A and Bowtell DDL. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome. Clin Cancer Res 2008;14:5198-5208 |
|
Scurr LL, Guminski AD, Chiew YE, Balleine RL, Sharma R, Lei Y, Pryor K, Wain GV, Brand A, Byth K, Kennedy C, Rizos H, Harnett PR, and deFazio, A. Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer Clin Cancer Res 2008;14:6924-6932 |
|
Anglesio, M., Arnold, J., George, J., Tinker, A., Tothill, R., Waddell, N., Simms, L., Locandro, B., Fereday, S., Traficante, N., Russell, P., Sharma, R., Birrer, M., Australian Ovarian Cancer Study Group, deFazio, A., Chenevix-Trench, G., and Bowtell, D. Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors Mol Cancer Res 2008;6:1678-1690 |
|
Gomes, L., Mackie, N., Catchpoole, D., Henwood, T. Test and Teach - In a fix about immunohistochemistry on 60 year old tissue blocks?. Journal of Histotechnology. 2008; 8:125.
|
| |
|
Research published in 2007 using tissue specimens supplied by ABN-Oncology-affiliated tissue banks |
|
Zeps, N. Iacopetta, B.J. Schofield, L. George, J.M. & Goldblatt, J. (2007) 'Waiver of individual consent in research: When do potential benefits to the community outweigh private rights?', Medical Journal of Australia 186(2): 88-90 |
|
Craig C. Whiteford, Sven Bilke, Braden T. Greer, Qingrong Chen, Till A. Braunschweig, Nicola Cenacchi, Jun S. Wei, Malcom A. Smith, Peter Houghton, Christopher Morton, C. Patrick Reynolds, Richard Lock, Richard Gorlick, Chand Khanna, Carol J. Thiele, Mikiko Takikita, Daniel Catchpoole, Stephen M. Hewitt and Javed Khan. “Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis”. Cancer Research 2007;67 (1). January, 2007 |
|
Greenman C, Stephens P, Smith R, Dalgliesh G, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O’Meara S, Vastrik I, Schmidt E, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew Y-E, deFazio A, Greaves MF, Green AR, Birney E, Easton DF, Chenevix-Trench G, Khoo SK, Tan M-H, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR. Patterns of somatic mutation in human cancer genomes. Nature 446:153-158, 2007 |
|
Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW. Combined CA125 and Mesothelin Levels for the Diagnosis of Malignant Mesothelioma. Chest 2007; 132(4): 1239-1246 |
|
Creaney J, Yeoman D, Naumoff LK, Hof M, Segal A, Musk AW, De Klerk N, Horick N, Skates SJ & Robinson BWS. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 2007; 62(7): 569-576 |
|
Catchpoole D.R., Lail A., Guo D., Chen Q., Khan J. Gene expression profiles that segregate patients with childhood acute lymphoblastic leukaemia: An independent validation study identifies that endoglin associates with patient outcome. Leukaemia Research 2007; 31(12): 1741-1747 |
| |
|
Research published in 2006 using tissue specimens supplied by ABN-Oncology-affiliated tissue banks |
|
Stallings R.L., Nair P., Maris J.M., Catchpoole D.R., McDermott M., Breatnach F. and O’Meara A. High resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Research, 66(7), 3673-3680, 2006. |
|
Barbaric D, Byth K, Dalla-Pozza L, Byrne JA (2006). Expression of tumor protein D52-like genes in childhood leukemia at diagnosis: Clinical and sample considerations Leukemia Research Volume 30, Issue 11, Pages 1355-1363 |
|
Han Qian Feng, Anne-Marie Shearwood, Zhao Wen Ying, Nik Zeps, David Joseph, Barry Iacopetta, Arun Dharmarajan sFRP-4 and beta-catenin in Colorectal Carcinoma. Cancer Letters 231 (2006) 129-137 |
|
Powell A, Creaney J, Broomfield S, Van Bruggen I, Robinson B. Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma Lung Cancer Volume 52, Issue 2 , Pages 189-197 |
|
Holloway AJ, Diyagama DS, Opeskin K, Creaney J, Robinson BW, Lake RA, Bowtell DD. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions. Clin Cancer Res 2006;12:5129-5135 |
|
Creaney J, Christansen H, Lake R, Musk AB, de Klerk N, Robinson BW. Soluble mesothelin related protein in mesothelioma J Thorac Oncol. 2006;1: 172–174 |
| |
|
Research published in 2005 using tissue specimens supplied by ABN-Oncology-affiliated tissue banks |
|
Astuti D., Latif F., Wagner K., Gentle D., Cooper W.N., Catchpoole D.R., Grundy R., Ferguson-Smith A.C. and Maher E. (2005) Epigenetic alteration at the DLK-GTL2 imprinted domain in human neoplasia provides evidence for trans interaction between DLK1 and GTL2. British Journal of Cancer 92, 1574-1580 |
|
Gorringe, KL., Boussioutas, A., The Melbourne Gastric Cancer Group, Peter Mac Microarray Facility, Bowtell, DDL. (2005) Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization Genes, Chromosomes and Cancer 42(3): 247-259 |
|
Henson J.D., et al. (2005) A robust assay for alternative lengthening of telomeres in tumours shows the significance if alternative lengthening of telomeres in sarcomas and astrocytomas Clinical Cancer Research 11, 217-225 |
|
Sven Bilke, Qing-Rong Chen, Frank Westerman, Manfred Schwab, Daniel Catchpoole, Javed Khan Inferring a Tumour Progression Model for Neuroblastoma from Genomic dataJournal of Clinical Oncology 23(29),2005 |
|
Margetts C.D.E., Astuti D., Gentle D.C., Cooper W.N., Cascon A., Catchpoole D.R., Robledo M., Neumann H.P.H., Latif F. and Maher E.R. (2005) Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DcR1, DcR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal allele loss in VHL and sporadic phaeochromocytomas Endocrine-Related Cancer 12, 161-172 |
|
Aghmesheh, M., Edwards, L., Clarke, C.L., Byth, K., Katzenellenbogen, B.S., Russell, P.J., Friedlander, M., Tucker, K.M. and deFazio, A.(2005) Expression of steroid hormone receptors in BRCA1 -associated ovarian carcinomas Gynecologic Oncology 97: 16-25 |
|
Robinson BWS, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. (2005) Soluble mesothelin-related protein – A blood test for mesothelioma Lung Cancer 49,S1:S109-S111. |
|
Mitchell, G., Antill, Y.C., Murray, W., Kirk, J., Salisbury, E., Lindeman, G.J., Di Iulio, J., Milner, A.D., Devereaux, L., Phillips, K. (2005) Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation Breast Cancer Research 7:R1122-R1131 |
|
Creaney J, Robinson BWS. (2005) Detection of mesothelioma in asbestos exposed individuals: The potential role of soluble mesothelin related protein Hematol Oncol Clin North Am. Dec;19(6):1025-40 |
|
Morgan T., Atkins G.J., Trivett, M.K., Johnson, S.A., Kansara, M., Schlicht, S., Slavin, J.L., Simmons, P., Dickinson, I., Powell, G.J., Choong, P.F.M., and Thomas, D.M. (2005) Molecular Profiling of Giant Cell Tumor of Bone and the Osteoclastic Localization of Ligand for Receptor Activator of Nuclear Factor κB American Journal of Pathology 167(1): 117-28. |
| |
|
Research published in 2004 and earlier using tissue specimens supplied by ABN-Oncology-affiliated tissue banks |
|
Boussioutas, A., Li, H., Liu, J., Waring, P., Lade, S., Holloway, AJ., Taupin, D., Gorringe, K., Haviv, I., Desmond, P.V., and Bowtell, DDL. (2003) Distinctive Patterns of Gene Expression in Premalignant Gastric Mucosa and Gastric Cancer Cancer Research 63(10): 2569-2577 |
|
Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. (2003) Mesothelin-family proteins and diagnosis of mesothelioma. The Lancet 362(9396):1612-6 |
|
Chen Q-R., Bilke S., Wei J.S., Whiteford C.C., Cenacchi N., Krasnoselsky A.L., Greer B., Son C-G., Westermann F., Berthold F., Schwab M., Catchpoole D.R., and Khan J. (2004) cDNA Array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics, 5, 70 |
|
Thomas, D.M., Johnson, S.A., Sims, N.A., Trivett, M., Slavin, J.S., Waring, P. Rubin, B.P., McArthur, G., Walkley, C., Grim, J.E., Clurman, B., Holloway, A., Diyagama, D., Bowtell, D.D.L., Lee, J-S., Gutierrez, G., Piscopo, D.M., Carty, S.A., Hinds, P.W. (2004) Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. Journal of Cell Biology 167: 925-34. |
|
Wei J.S., Greer B.T., Steinberg S., Son C-G., Chen Q-R., Westermann F., Whiteford C.C., Bilke S., Cenacchi N., Catchpoole D.R., Berthold F., Schwab M. and Khan J. (2004) Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Research 64(19), 6883-6891 |
|
Chai M, Zeps N, Joseph D, Goldblatt J, Harvey J, Charles A, Iacopetta B (2004) Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients. Clinical Gastroenterology and Hepatology 2(11):1017-25 |
|
Robinson BWS. Soluble mesothelin-related protein – a sensitive new marker for mesothelioma. Am J Oncol Rev. 2004;3:230-233 |
| |
|
|
| |
Last Update on:
Friday 29-Jul-2011 4:36 PM
© Copyright: Australasian Biospecimen Network (ABN)
All rights reserved |
| |
|
